Electrocardiography

Electrocardiograms (ECG) are a primary cardiac diagnostic test that measures the electrical activity in heart to identify overall cardiac function, arrhythmias and areas of ischemia and infarct. Standard 12-lead ECG breaks the 3D structure of the heart into 12 zones, each showing the electrical activity in that specific area of the heart. This narrows down areas where there are issues with coronary artery disease or electrophysiology issues. Many ambulatory heart monitors and consumer-grade ECG monitors use fewer leads so are less specific as to cardiac conditions or location of abnormal heart rhythms, but can show an issue that requires further diagnostic testing or treatment.

AIM: Screening student athletes with ECG reduces costs, adds life years

Compared with no screening, screening young athletes with a 12-lead ECG, coupled with cardiovascular-focused history and physical exams, can significantly reduce costs and add years of life, according to a study published in the March 2 issue of the Annals of Internal Medicine.

CCI: Pre-hospital ECG significantly reduces door-to-balloon times

Individuals experiencing chest pain who had ECG assessments prior to arriving at the hospital experience a significantly reduced time-to-treatment or door-to-balloon time, based on a study in the January issue of Catheterization and Cardiovascular Interventions (CCI).

CardioComm begins shipping ECG management software

CardioComm Solutions has shipped its Global ECG Management System (GEMS) software as part of a multi-year North American licensing agreement with GE Healthcare, and a subsequent OEM agreement.

Zoll aligns with Inovise for ECG technology

Zoll Medical, a manufacturer of resuscitation devices and related software solutions, has entered into a multi-year agreement to license Inovise Medical's Audicor technology.

Report: Cost savings will drive ECG global market to nearly $160M by 2015

The global electrocardiography (ECG) market is expected to reach $157.9 million in 2015 with an annual growth rate of 3.7 percent, compared with a market valued at $122.2 million in 2008, according to estimates from market research firm GlobalData.

JAMA: Common ECG finding may indicate serious cardiac problems

A routine electrocardiogram (ECG) that signals a disorder of the electrical conducting system in one part of the heart previously believed to be benign is associated with an increased risk for atrial fibrillation, pacemaker implantation or death, according to a study in the June 24 issue of the Journal of the American Medical Association.

FDA approval brings GE portable ECG to U.S.

The FDA has cleared GE Healthcare's MAC 800, a portable electrocardiogram (ECG) device based on cell phone technology, which will immediately be introduced into the U.S. market.

ECG Image Management Brings Increased Productivity and Confidence

Seamlessly integrating ECG information into electronic medical records is imperative in today’s totally connected medical enterprise. Managing ECG image capture and report generation leads to a more efficient use of resources, as well as better patient outcomes.

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.